Search research articles
Contact Us
Filters
Showing results (151-160 of 267) with videos related to
Page
of 27
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 20, 2008
Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia
Brad Spellberg, George H Talbot, Eric P Brass, et al.
Antimicrobial Agents and Chemotherapy
|
July 28, 2006
Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis
Gunter Rieg, Brad Spellberg, Julie Schwartz, et al.
Antimicrobial Agents and Chemotherapy
|
February 28, 2023
Therapeutic, Humanized Monoclonal Antibody Exhibits Broad Binding and Protective Efficacy against Acinetobacter baumannii
Matthew Slarve, Zeferino Reyna, Elizabeth Burk, et al.
Antimicrobial Agents and Chemotherapy
|
January 26, 2011
Combination therapy of murine mucormycosis or aspergillosis with iron chelation, polyenes, and echinocandins
Ashraf S Ibrahim, Teclegiorgis Gebremariam, Guanpingsheng Luo, et al.
The Journal of Infectious Diseases
|
May 26, 2021
Monoclonal Antibody Requires Immunomodulation for Efficacy Against Acinetobacter baumannii Infection
Travis B Nielsen, Jun Yan, Brian M Luna, et al.
Msphere
|
November 24, 2021
<i>In Vitro</i> Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae
Bosul Lee, Jun Yan, Amber Ulhaq, et al.
Clinical and Vaccine Immunology : CVI
|
January 11, 2008
Considerable differences in vaccine immunogenicities and efficacies related to the diluent used for aluminum hydroxide adjuvant
Lin Lin, Ashraf S Ibrahim, Valentina Avanesian, et al.
Plos One
|
June 13, 2023
Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates
Peggy Lu, Francesco Alletto, Bosul Lee, et al.
Antimicrobial Agents and Chemotherapy
|
January 28, 2005
Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis
Ashraf S Ibrahim, Joel C Bowman, Valentina Avanessian, et al.
The Journal of Antimicrobial Chemotherapy
|
March 6, 2012
Diabetic murine models for Acinetobacter baumannii infection
Guanpingsheng Luo, Brad Spellberg, Teclegiorgis Gebremariam, et al.
Page
of 27
Search research articles
Search
Showing results (151-160 of 267) with videos related to
Sort By:
Page
of 27
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 20, 2008
Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia
Brad Spellberg, George H Talbot, Eric P Brass, et al.
Antimicrobial Agents and Chemotherapy
|
July 28, 2006
Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis
Gunter Rieg, Brad Spellberg, Julie Schwartz, et al.
Antimicrobial Agents and Chemotherapy
|
February 28, 2023
Therapeutic, Humanized Monoclonal Antibody Exhibits Broad Binding and Protective Efficacy against Acinetobacter baumannii
Matthew Slarve, Zeferino Reyna, Elizabeth Burk, et al.
Antimicrobial Agents and Chemotherapy
|
January 26, 2011
Combination therapy of murine mucormycosis or aspergillosis with iron chelation, polyenes, and echinocandins
Ashraf S Ibrahim, Teclegiorgis Gebremariam, Guanpingsheng Luo, et al.
The Journal of Infectious Diseases
|
May 26, 2021
Monoclonal Antibody Requires Immunomodulation for Efficacy Against Acinetobacter baumannii Infection
Travis B Nielsen, Jun Yan, Brian M Luna, et al.
Msphere
|
November 24, 2021
<i>In Vitro</i> Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae
Bosul Lee, Jun Yan, Amber Ulhaq, et al.
Clinical and Vaccine Immunology : CVI
|
January 11, 2008
Considerable differences in vaccine immunogenicities and efficacies related to the diluent used for aluminum hydroxide adjuvant
Lin Lin, Ashraf S Ibrahim, Valentina Avanesian, et al.
Plos One
|
June 13, 2023
Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates
Peggy Lu, Francesco Alletto, Bosul Lee, et al.
Antimicrobial Agents and Chemotherapy
|
January 28, 2005
Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis
Ashraf S Ibrahim, Joel C Bowman, Valentina Avanessian, et al.
The Journal of Antimicrobial Chemotherapy
|
March 6, 2012
Diabetic murine models for Acinetobacter baumannii infection
Guanpingsheng Luo, Brad Spellberg, Teclegiorgis Gebremariam, et al.
Page
of 27